你怎么看这家公司？
应用层生命科学成立于 2022总融资 $8M
Promise Bio, founded in 2022 in Tel Aviv, has developed a cloud-based AI platform that analyzes protein modifications in blood samples to predict treatment response in patients with autoimmune diseases.
资本关系图
创始人 / 核心团队
投资方
融资历史
- 2024-12种子轮$8M